Healthleap raises $38M to expand hospital AI that flags at-risk patients

Healthleap has raised $38 million in seed and Series A funding for its AI platform that reads hospital patient records to identify people at risk of undiagnosed illnesses. The financing includes an $8 million seed round co-led by Sequoia Capital and First Round Capital, plus a $30 million Series A led by Hummingbird Ventures. The company is not disclosing its valuation.

The platform connects to a hospital’s electronic health record system and analyzes both structured data, such as labs and vital signs, and written clinical notes. It uses language models to pull signals from notes, then combines those findings with risk models to surface patients who may need a closer look. Healthleap says its software does not diagnose patients; it highlights items for additional review.

Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, Healthleap began with a clinical nutrition tool built for dietitians. The company later pivoted to a broader platform aimed at finding hospital patients with conditions that may not be identified early enough, including malnutrition and delirium. It has also built programs for aspiration pneumonia, pressure ulcers, and readmission risk for congestive heart failure, which are undergoing further clinical validation.

Healthleap says its platform is deployed in more than 50 hospitals, up from three hospital partners over the past year. Customers now include Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare, and the company says revenue grew more than 10x over the same period without disclosing specifics. Healthleap plans to spend the new funding on engineering, product, sales, and customer success as it adds support for more conditions, with a stated goal of covering more than 40 major health conditions and expanding into outpatient and home care.